Using a focus assay we have shown that the entire human papillomavirus type 16 (HPV-16) genome is capable of cooperating with an activated ras oncogene to transform secondary rat embryo fibroblast (REF) cells as indicated by focus formation of unselected cells. However, this assay failed to detect any similar activity with either the whole HPV-6 genome or with subgenomic fragments. In contrast, transformed colonies appeared when G418 (geneticin)-resistant colonies were selected after cotransfection with activated ras DNA and either the entire HPV-6 genome or subgenomic fragments containing the E6/E7 open reading frames (ORFs) of HPV-6 or HPV-16. The transformation assessment was based on the development of a rastransformed appearance in G418-resistant colonies. The appearance of this morphology did not imply the ability of transformed cells to produce colonies in semi-solid agarose (anchorage-independent growth), and extended culture for about l0 to 20 population doublings was necessary before transfected cells exhibited anchorageindependent growth. Transformation of REF cells was not observed with the E50RF of HPV-16 under the control of an exogenous promoter (the long terminal repeat of Rous sarcoma virus) in cooperation with activated ras DNA. No transformation was observed using an activated myc oncogene with either HPV-6 or HPV-16 DNA.
INTRODUCTION
Human papillomavirus types 6 and 16 are associated with genital lesions. HPV-6 is predominantly associated with condylomata acuminata (genital warts) and mild cervical dysplasias, while HPV-16 is associated with all grades of cervical dysplasias but, unlike HPV-6, is involved in progressive disease and malignancy (Dfirst et al., 1983; Campion et al., 1986) .
In the absence of a cell culture system capable of supporting virus propagation (Butel, 1972 ) studies are largely confined to recombinant HPV DNA. HPV-16 DNA has been shown to be capable of transforming contact-inhibited mouse fibroblast (3T3) cells (Tsunokawa et al., 1986; Yasumoto et al., 1986) . It has also been shown that the E6/E7 open reading frame (ORF) of HPV-16 can cooperate with an activated ras oncogene to transform baby rat kidney (BRK) cells (Matlashewski et al., 1987) . This transforming activity has been further delimited to the E7 ORF using BRK cells (Phelps et al., 1988) and rat 3Y1 cells (Kanda et al., 1987) , a continuous cell line. The E70RF under the control of the simian virus 40 (SV40) early promoter has also been shown to be capable of transforming NIH 3T3 cells (Phelps et al., 1988) . Thus the E70RF appears to encode both an immortalizing function comparable with that of the myc oncogene and a transforming function comparable with that of the ras oncogene.
We have investigated the transforming potential of HPV-6 and HPV-I 6 in order to try to find a biological basis for the difference between the oncogenic effects of these viruses following infection in vivo.
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Rat embryo fibroblast (REF) cells
were transfected with either pSV2neo/HPV-6 or pSV2neo/HPV-16 plasmid DNA, together with Ha-ras DNA, and transformation was assessed both before and after selection with G418 (Geneticin; Bethesda Research Laboratories). We show, in contrast to previously published reports, that HPV-6 DNA as well as HPV-16 DNA can fully transform REF cells in cooperation with Ha-ras DNA. However, G418 selection and a number of rounds of replication were essential before HPV-6 DNA was able to transform these cells.
METHODS
Cells. Primary REF cells were obtained from Whittaker MA Bioproducts (Baltimore, Md., U.S.A.) as confluent monolayers, which were then resuspended and stored frozen in liquid nitrogen.
Plasmid constructs. The constructs used are shown in Fig. 1 . Full-length HPV-6 and HPV-16 DNA was cloned at the BamHI site of pSV2neo (Southern & Berg, 1982 ) orientated 5'-3' with respect to the direction of transcription from the SV40 promoter. The HPV-6 E6/E7 construct was prepared by EcoRI digestion of full-length HPV-6 DNA cloned in pSV2neo at the BamHI site. There is a second EcoRI site in the pSV2neo sequence 3' to the HPV-6 DNA insert, pSV2neo/HPV-6 DNA thus deleted between the EcoRI and BamHI sites of the HPV-6 insert was then re-ligated. A similar procedure was adopted to prepare the HPV-16 E6/E7 construct. Full-length HPV-16 DNA cloned at the BamHI site of pSV2neo was digested with KpnI and re-ligated. There are two KpnI sites in HPV-16 and none in pSV2neo. The plasmid with HPV-16 E5 was constructed by cloning the PstI fragment shown (Fig. 1) into the PstI site of pGem2 (Promega Biotec, Madison, Wis., U.S.A.), excising by digestion with restriction endonucleases BamHI and HindIII, which have sites on either side of PstI in pGem2, and cloning between the HindIII and BamHI sites of pRSVneo, pRSVneo is identical to pSV2neo except for the substitution of the long terminal repeat (LTR) of the Rous sarcoma virus for the SV40 promoter (Gorman et al., 1983) . Cloning the E5 sequence between the BamHI and HindlII sites removes the gene for neomycin resistance (neo) and puts the E5 sequence adjacent to the LTR. The E5 sequence was orientated 5'-3" with respect to the orientation of the LTR. pEJras DNA (a Ha-ras clone; Parada et al., 1982) was a gift from Dr C. Marshall of the Chester Beatty Institute, London, U.K. pLTRmyc (an activated clone of the myc oncogene) (Kelekar & Cole, 1986 ) was a gift from Dr L. Laimins, Howard Hughes Medical Institute, Chicago, Ill., U.S.A.
Transfection of REFceUs. All transfections involved DNA containing the neo gene (pSV2neo; Southern & Berg, 1982) to allow selection of transfected cells using G418. The combinations of DNA used are tabulated in Results. Each DNA species was used in 25 ktg quantities except pSV2neo, of which 10 ~tg quantities were used. These DNA levels approach saturation levels for the competent cell population (unpublished data). This ensured that most of the competent cells were transfected with each DNA species.
The calcium phosphate co-precipitation method of Graham & van der Eb (1973) was used. Ceils were seeded from frozen storage into 90 mm diameter Petri dishes containing 10 ml of Dulbecco's modified Eagle's medium (DMEM) supplemented with 10~ foetal bovine serum (FBS; Sera-lab, Crawley Down, U.K.). After overnight incubation fresh growth medium was applied to the cells, followed 3 h later by the calcium phosphate/DNA precipitate. The precipitate was left in contact with the cells for approx. 20 h before being washed off using medium not containing serum, and fresh growth medium was applied. After a further 24 h incubation, the cells from each plate were removed by trypsinization and divided equally between two 90 mm Petri dishes. Cells on one plate of each pair were grown unselected in growth medium as before; cells on the second plate were selected by addition of G418 to 300 ttg/ml (equivalent to t 50 ~tg/ml active drug). Cells were incubated for up to 3 weeks with regular changes of medium.
Transformation assessment. Plates not containing G418 (focus assay) were scored by staining confluent monolayers with 4~ Giemsa stain, containing formaldehyde, for 30 min and then counting multi-layered foci of cells not displaying contact inhibition. Plates of cells treated with G418 were scored by counting G418-resistant colonies of cells showing a ras-transformed-like appearance. Assessment was based on four criteria: the microscopic appearance of the cells i.e. the typical ras phenotype of rounded highly refractile cells showing reduced adhesion, lack of contact inhibition resulting in multi-layered colonies of G418-resistant cells, extended growth in medium with a reduced (5%) serum content, and anchorage-independent growth in a semi-solid medium. Total colony formation was estimated after staining with 0.1~ methyl violet. Before staining, representative G418-resistant colonies of transformed appearance were picked off the plate and cultured in DMEM supplemented with 5 ~ FBS and G418 through two or three serial passages after initial transplantation, seeding at 10~ confluence each time. Colonies failing to grow to at least 50~ confluence within 2 to 3 weeks were discarded and scored as negative. Surviving colonies were seeded into semi-solid (0-3%) agarose medium at a concentration of 104 cells/60 mm diameter Petri dish. Agarose medium consisted of DMEM supplemented with 10% FBS and melted agarose. Colonies were stained overnight using an aqueous solution ofp-iodonitrotetrazolium violet (1NT; Sigma) at a concentration of 1 g/l. After staining, the soft agarose overlays were decanted onto Whatman 3MM chromatography paper and allowed to dry. DNA analysis. Total DNA was extracted from representative colonies according to the method of Wigler et al. (1979) . After digestion with BamHI restriction endonuclease (Anglian Biotech. Ltd., Colchester, U.K.) DNA samples were subjected to electrophoresis, together with undigested samples and marker DNA, through a 0.8 agarose gel. DNA was transferred to nitrocellulose by Southern transfer (Southern, 1975) after partial depurination (Wahl et al., 1979) , and hybridization was carried out under optimum conditions using HPV DNA purified free of plasmid and labelled to high specific activity (/> 4 × 108 d.p.m./~tg DNA) by the random primer oligolabelling method of Feinberg & Vogelstein (1983) . The nitrocellulose was washed under conditions of high stringency (Tin -10 °C) before autoradiography, which was carried out at room temperature using Fuji RX X-ray film.
Athymic mice experiments. Representative clones were tested for tumourigenicity by subcutaneous inoculation into athymic nude mice. Three mice were used for each clone and each mouse was inoculated with 106 cells at each of two sites.
RESULTS
Focus assay
REF cells were transfected with full-length HPV-6 and HPV-16 DNA, and subgenomic fragments were cloned into the pSV2neo or pRSVneo vectors as described in Methods.
Following transfection, the cells were grown for 24 h, removed by trypsinization and divided equally between two 90 mm diameter Petri dishes. Cells in one dish were grown unselected and were observed for the production of transformed loci over a period of 3 weeks.
The focus assay (Table 1) shows that significant focus formation was observed only after cotransfection with pSV2neo/HPV-16 whole genomic DNA+pEJras DNA (compare pLTRmyc DNA + pEJras DNA + pSV2neo DNA and pEJras DNA + pSV2neo DNA). This indicates that the entire HPV-16 genome, but not the entire HPV-6 genome nor the subgenomic fragments of either, is capable of cooperating with pEJras DNA to induce the transformed state in unselected secondary REF cells. This is in part consistent with published data (Matlashewski et al., 1987) . The appearance of typical loci before and after staining with Giemsa is shown in Fig. 2 (a, b) and 3 respectively. Significant focus formation was not observed following cotransfection with activated myc and pSV2neo/HPV-16 DNA (Table 1) .
G418 selection assay
Transfected cells on the second of each pair of Petri dishes were selected for resistance to G418. This G418 selection assay (Table 2 ) supported the result of the focus assay with respect to whole genomic HPV-16 DNA. In separate experiments 73 ~ of G418-resistant colonies showed a transformed appearance (Fig. 2c) and cells from each of 12 of these transformed colonies showed anchorage-independent growth in semi-solid agarose medium (Fig. 4a ) after passage in medium with reduced serum as described in Methods. Thus pSV2neo/HPV-16 DNA in combination with an activated ms oncogene fulfils all of the criteria for transformation set out in Methods (Transformation assessment).
However, with respect to the results obtained using the other DNA constructs examined, the G418 selection assay diverges from the focus assay.
Transformation
From Table 2 it can be seen that a typical transformed appearance was shown by 37~ of the G418-resistant colonies obtained by transfection with pSV2neo/HPV-16 E6/E7+pEJras DNA, 45 ~ of those obtained using pSV2neo/HPV-6 + pEJras DNA (Fig. 2d ) and 38 ~ of those obtained using pSV2neo/HPV-6 E6/E7 + pEJras DNA. The comparable figure for the negative control (pEJras+ pSV2neo DNA) is 11~o and that for the positive control (pEJras+ pLTRmyc + pSV2neo DNA) is 88~. Growth in semi-solid agarose (Table 2 ) was shown by seven of 19 G418-resistant cell colonies of transformed appearance transfected with pEJras + pSV2neo/HPV-6 DNA (Fig. 4b) , seven of 15 for pEJras + pSV2neo/HPV-6 E6/E7 DNA, three of 22 colonies of cells transfected with pEJras + pSV2neo/HPV-16 E6/E7 DNA and two of 15 colonies of cells transfected with pEJras + pSV2neo DNA (negative control). In addition, eight colonies of cells of non-transformed appearance (flat cells, Fig. 2e ) transfected with pEJras + pSV2neo DNA were examined. The single colony that survived two serial passages in low serum medium to be seeded into agarose failed to show any growth in agarose (Fig. 4d) . It is characteristic of REF cells that have not been transformed to exhibit a slow growth rate in reduced (5 ~) serum and to have a limited life-span (unpublished data). All six colonies isolated after transfection with pEJras + pLTRmyc showed growth in agarose (Fig. 4c) . (Fig. 4d) .
Analysis of DNA DNA was extracted from typical clones of G418-resistant REF cells and analysed as described in Methods. Fig. 5 shows the result of hybridizing with the appropriate 32p-labelled HPV DNA probe cell DNA from two separate clones of REF cells transfected with pEJras + pSV2neo/HPV-16 DNA (Fig. 5a ) and from two separate clones transfected with pEJras + pSV2neo/HPV-6 DNA (Fig. 5b) . It can be seen that HPV DNA is present in these cells integrated with the host genome (compare undigested cell DNA samples in Fig. 5 (Fig. 5b ). There were approximately 10 copies/cell of HPV-16 DNA and about 40 copies/cell of HPV-6 DNA in these clones.
Since ORF E5 is the major transforming gene of bovine papillomavirus type 1 (BPV-1) we investigated the transforming ability of ORF E5 of HPV-16. By itself, under the strong promotion of the RSV LTR the E50RF was unable to transform REF cells in cooperation with ras after selection with G418. Since the whole of the early region of HPV-16 transformed more efficiently than the E6/E7 region only, it is possible that some other function from the rest of the early region is important for efficient transformation. To investigate possible cooperation between putative transforming genes we carried out a cotransfection of REF ceils using the following three DNA species: the plasmid containing the E6/E70RF, that containing the E5 ORF under the control of the RSV LTR, and pEJras DNA. Twenty-two colonies from 71 present (31 ~) appeared to be transformed, but this level was not above that obtained with ORF E6/E7 and pEJras DNA (Table 2 ). In addition, no foci were observed in unselected cells above the background given by pEJras DNA when cells were transfected with pEJras + pRSV/HPV-16 E5 DNA (Table 1) . Therefore pSV2neo/HPV-16 E5 + pEJras DNA showed no significant transforming ability by any of the criteria employed. Table 2 shows the transformation efficiency of each DNA combination used for transfection. This is an estimate of the proportion of transfected cells that become fully transformed, as DNA gave efficiencies significantly higher than the pEJras negative control. Both HPV-6 constructs, pSV2neo/HPV-6 (17~) and pSV2neo/HPV-6 E6/E7 (18~) showed similar efficiencies, in each case about a quarter of the efficiency of pSV2neo/HPV-16 and about nine times that of the negative control. None of the D N A constructs tested showed significant cooperation with activated myc DNA (Table 2) . Tumourigenicity The tumourigenicity of REF cells transformed to anchorage-independent growth was tested by inoculation into athymic nude mice as described in Methods. Three such clones of cells transfected with pEJras DNA together with pSV2neo/HPV-16, pSV2neo/HPV-6 or pLTRmyc + pSV2neo D N A were tested. In addition, one clone of non-transformed cells transfected with pEJras + pSV2neo D N A was used as a negative control. Each of the clones, except the negative control, induced the development of large (0.5 to 1 cm diameter) tumours at each site of inoculation within 14 days. The control mice showed no tumour development after 27 days. This indicates that REF cells transformed to anchorage-independent growth are fully tumourigenic in vivo.
Cooperation with ras
A significant observation was that the entire HPV-16 genome without pEJras cooperation exhibited a low transforming ability, with 14 of 324 G418-resistant colonies (4~) showing a 'transformed' appearance. Although at first none of the colonies tested showed a typical rastransformed appearance (Fig. 2f) REF cells (Fig. 2e) . After three serial passages, seeding at 10~ confluence, 12/14 developed a typical ras-transformed appearance (Fig. 2g) and eight grew into colonies in agarose. None of the other DNA constructs tested showed significant transforming ability in the absence of pEJras DNA.
DISCUSSION
Previous work (Matlashewski et al., 1987) using both a focus assay and a G418 selection assay has indicated that the E 6 / E 7 0 R F of HPV-16 D NA expressed under the control of a retroviral LTR can cooperate with an activated ras oncogene to transform primary BRK cells. Transformation was assessed by focus formation and by the morphology of G418-resistant colonies. Other published results (Phelps et al., 1988 ; Kanda et al., 1987) are in agreement with these findings.
Our results show that assessment of the transforming ability of HPV DNA in cooperation with an activated ras oncogene depends upon the method used. Using a focus assay, only whole genomic HPV-16 DNA shows transforming potential to any significant extent in these experiments. However, using the G418 selection procedure and assessing the morphological appearance (Table 2 ) of selected colonies, transforming potential is shown by whole genomic HPV-16 and HPV-6 D N A and by DNA sequences including the E 6 / E 7 0 R F of each viral type. However, when a representative selection of these colonies was examined further by extended growth in reduced (5 ~) serum, followed by examination of the ability of the surviving cells to grow in semi-solid agarose, cells transfected with pSV2neo/HPV-16 E6/E7 + pEJras D N A failed to show any significant activity (Table 2) .
These results seem to indicate that there are degrees of transformation, with morphological appearance being an early marker and focus formation and growth in semi-solid agarose being late markers, indicative of complete transformation to malignancy, as suggested by the result of inoculation of transformed REF cells into athymic nude mice. On this basis whole genomic HPV-16 DNA in conjunction with an activated ras oncogene is sufficient to effect complete transformation of REF cells whereas HPV-16 E6/E7 DNA is not, although previous work shows that it is necessary since a small deletion in this region was found to abolish the transforming ability of HPV-16 DNA in conjunction with pEJras DNA (Matlashewski et al., 1987) .
There was also no significant difference in the efficiency of transformation, as judged by the appearance of a typical ras phenotype, obtained using pSV2neo/HPV-16 E6/E7 + pEJras DNA and that obtained using pSV2neo/HPV-16 E6/E7 + pRSV/HPV-16 E5 + pEJras DNA (Table  2) . Neither was there significant focus formation using pSV2neo/HPV-16 E6/E7 + pRSV/HPV-16 E5 + pEJras DNA (data not shown). This indicates the involvement of some other part of the genome, either another transforming sequence or a sequence required for efficient expression of the E6/E7 product, as full-length HPV-16 DNA in cooperation with activated ras DNA exhibited greater transformation efficiency (Table 2 ). One explanation is that, unlike full-length HPV-16, the E6/E7 construct does not contain a polyadenylation signal and so RNA may not be properly processed. However, in view of the results obtained with pSV2neo/HPV-6 E6/E7 DNA discussed below this seems unlikely.
In contrast, we found no significant difference between the transforming potential of fulllength HPV-6 DNA and the HPV-6 E6/E7 construct. Although the transforming potential was lower than that of full-length HPV-16 DNA, it was markedly higher than that of the negative control. This indicates that the transforming potential of HPV-6 DNA is fully expressed by the E6/E7 ORF. In this context it should be noted that the pSV2neo/HPV-6 E6/E7 construct, like the pSV2neo/HPV-16 E6/E7 construct, lacks a papillomavirus polyadenylation signal, yet this does not affect its transforming ability as compared with that of the full-length HPV-6 construct. This indicates that the apparent lack of a papillomavirus polyadenylation signal is not responsible for the lack of transforming activity shown by the pSV2neo/HPV-16 E6/E7 construct. Since both constructs are integrated within the host genome it is likely that a host polyadenylation site is used. The results obtained with HPV-16 DNA are at variance with published results showing that the E6/E7 ORF (Matlashewski et al., 1987) or the E7 ORF alone (Phelps et al., 1988; Kanda et al., 1987 ) is capable of transforming BRK cells and rat 3Y1 cells. However, these results were obtained using DNA constructs in which the ORFs were expressed under control of a strong exogenous promoter. Our results rely on expression by endogenous promoters, except for the HPV-16 E5 construct which is under control of the RSV LTR. Therefore, it is possible that in the full-length HPV-16 construct, the endogenous promoter is activated by another sequence absent from the E6/E7 construct used. This could be the E20RF since this is known to be involved in trans-activation of promoters in the non-coding region of both BPV-1 (Haugen et al., 1987; Spalholz et al., 1987) and HPV-16 (Phelps & Howley, 1987) . Support for this possibility is given by results obtained following transfection of rat 3Y1 cells, a continuous cell line, with a plasmid-cloned deletion mutant of HPV-16, in which the E6/E7 region was the only intact early ORF, and its expression relied upon endogenous HPV-16 promoters. Lower efficiencies of focal transformation were obtained than with full-length HPV-16 DNA (Watanabe & Yoshiike, 1988) . In our experiments with HPV-6 DNA, both the fulllength genome and the E6/E7 construct showed similar transformation efficiencies, indicating that trans-activation of HPV promoters is not involved in transformation by HPV-6 DNA as it appears to be with HPV-16 DNA transformation. This may explain, at least in part, the lower level of transformation by HPV-6 DNA observed in these experiments.
None of the HPV-16 or HPV-6 DNA constructs used cooperated with the activated myc oncogene to transform REF cells (Table 2) . However, published results show that the E7 ORF of HPV-16 is capable of transforming NIH 3T3 mouse cells, thereby showing a ras-like characteristic (Phelps et al., 1988) . This also may be a consequence of the use of a strong exogenous promoter to express the ORF, causing over-expression of the transforming product. This possibility is supported by the fact that ras has been shown to have immortalizing functions (Spandidos & Wilkie, 1984) and myc has been shown to have transforming functions (Keath et al., 1984) when over-expressed.
Our results also show that pSV2neo/HPV-16 DNA alone can transform REF cells at a low frequency without the presence of cotransfecting ras DNA, indicating that the HPV-16 genome encodes both immortalizing and transforming functions, albeit that the transforming (ras-like) function is expressed at a low level by endogenous HPV-16 promoters. This is consistent with the results published by Phelps et al. (1988) .
The stepwise nature of cellular transformation which we postulate here is supported to some extent by preliminary observations that some G418-resistant clones that failed to grow in semisolid agarose at the first or second passage subsequently grew at the second or third passage (three to four population doublings between passages). This is consistent with results obtained by Meneguzzi et al. (1984) following transfection of FR3T3 rat fibroblasts with plasmid-cloned BPV-1 DNA. Most of the G418-resistant clones that they isolated retained the morphology and growth control of normal fibroblasts. However, these clones underwent spontaneous transformation to produce foci with a frequency that increased with passage. Furthermore, Phelps et al. (1988) report that transformation is detected following transfection of NIH 3T3 mouse fibroblasts with HPV-16 DNA only if the cells are cotransfected with a selectable marker allowing suppression of growth of the background monolayer of non-transfected ceils. This is consistent with the need forextended growth for the expression of the transformed phenotype.
The fact that DNA from HPV-6 and HPV-16 appears to show differing degrees of transforming potential in vitro may facilitate the elucidation of the mechanism whereby HPV-16 appears to be involved in the development of malignancy in man.
